IL6 and anemia: It is worth noting that inhibition of the BMP signalling pathway, which drives hepcidin transcription, impairs its IL‐6‐mediated induction and may therefore represent a potential therapeutic target for modulating this pathway in cases of anaemia of inflammation [20].